Our top pick for
Yield10 Bioscience, Inc is an agricultural inputs business based in the US. Yield10 Bioscience shares (YTEN) are listed on the NASDAQ and all prices are listed in US Dollars. Yield10 Bioscience employs 25 staff and has a trailing 12-month revenue of around USD$744,000.
|Latest market close||USD$6.75|
|52-week range||USD$3.5 - USD$14.69|
|50-day moving average||USD$6.1637|
|200-day moving average||USD$6.2944|
|Wall St. target price||USD$16|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.801|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-05)||12.50%|
|1 month (2020-12-12)||N/A|
|3 months (2020-10-12)||-2.88%|
|6 months (2020-07-12)||N/A|
|1 year (2020-01-12)||N/A|
|2 years (2019-01-12)||N/A|
|3 years (2018-01-12)||329.94%|
|5 years (2016-01-12)||411.36%|
|Gross profit TTM||USD$-4,042,000|
|Return on assets TTM||-45.15%|
|Return on equity TTM||-198.83%|
|Market capitalisation||USD$22.5 million|
TTM: trailing 12 months
There are currently 54,412 Yield10 Bioscience shares held short by investors – that's known as Yield10 Bioscience's "short interest". This figure is 120.2% up from 24,711 last month.
There are a few different ways that this level of interest in shorting Yield10 Bioscience shares can be evaluated.
Yield10 Bioscience's "short interest ratio" (SIR) is the quantity of Yield10 Bioscience shares currently shorted divided by the average quantity of Yield10 Bioscience shares traded daily (recently around 43529.6). Yield10 Bioscience's SIR currently stands at 1.25. In other words for every 100,000 Yield10 Bioscience shares traded daily on the market, roughly 1250 shares are currently held short.
However Yield10 Bioscience's short interest can also be evaluated against the total number of Yield10 Bioscience shares, or, against the total number of tradable Yield10 Bioscience shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Yield10 Bioscience's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Yield10 Bioscience shares in existence, roughly 20 shares are currently held short) or 0.0188% of the tradable shares (for every 100,000 tradable Yield10 Bioscience shares, roughly 19 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Yield10 Bioscience.
Find out more about how you can short Yield10 Bioscience stock.
We're not expecting Yield10 Bioscience to pay a dividend over the next 12 months.
Yield10 Bioscience's shares were split on a 1:40 basis on 16 January 2020. So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Yield10 Bioscience shares – just the quantity. However, indirectly, the new 3900% higher share price could have impacted the market appetite for Yield10 Bioscience shares which in turn could have impacted Yield10 Bioscience's share price.
Over the last 12 months, Yield10 Bioscience's shares have ranged in value from as little as $3.5 up to $14.69. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Yield10 Bioscience's is 1.8388. This would suggest that Yield10 Bioscience's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for step-changing improvements in crop yield in the United States and Canada. The company, through its Trait Factory, is involved in developing high value seed traits for the agriculture and food industries. It also has an oilseed development center in Saskatchewan, Canada. Yield10 Bioscience, Inc. has research agreements with Bayer AG to develop traits in soybean; Forage Genetics International, LLC to develop traits in forage sorghum; J. R. Simplot Company to develop novel traits in potato; and GDM Seeds Inc. to evaluate yield traits in soybeans. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was founded in 1992 and is headquartered in Woburn, Massachusetts.
Everything we know about the Home Point Capital Inc IPO, plus information on how to buy in.
Everything we know about the ALFI INC IPO, plus information on how to buy in.
Steps to owning and managing CDAY, with 24-hour and historical pricing before you buy.
Steps to owning and managing CPF, with 24-hour and historical pricing before you buy.
Steps to owning and managing CFFI, with 24-hour and historical pricing before you buy.
Steps to owning and managing BPY, with 24-hour and historical pricing before you buy.
Steps to owning and managing BANF, with 24-hour and historical pricing before you buy.
Steps to owning and managing AVDL, with 24-hour and historical pricing before you buy.
Steps to owning and managing TEAM, with 24-hour and historical pricing before you buy.
Steps to owning and managing AUDC, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.